Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Latent representations of early brain development: A multivariate normative model of brain structure and behaviour.

Developmental cognitive neuroscience·2026
Same author

Pathways into child and adolescent mental health services for anxiety and depression: The role of social and educational factors.

European child & adolescent psychiatry·2026
Same author

Safety, efficacy, and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B.

Blood advances·2026
Same author

The association of clozapine treatment periods with incidence of exposure to assault and head injuries - a cohort study of electronic health records.

Frontiers in psychiatry·2026
Same author

Access and engagement with maternity, social care and mental health services for perinatal migrant women with no recourse to public funds and irregular status: A cross-sectional study using the eLIXIR born in South London, UK, maternity-child data linkage.

Public health·2026
Same author

The association between violence exposure and general and cause-specific mortality in people using mental health services: cohort study.

BJPsych open·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Sophie A Martin1, Francesca Biondo1,2, Amelia Jewell3

  • 1UCL Hawkes Institute, University College London, London, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

在研究数据上训练的人工智能模型可以预测现实世界NHS患者的痴呆症进展. 这些人工智能模型证明了早期痴呆风险评估的临床实用性.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经成像是一种神经成像.
  • 人工智能的人工智能
  • 痴呆症研究 痴呆症研究

背景情况:

  • 人工智能模型用于痴呆症预测通常使用精心策划的研究数据集,限制现实世界的概括性.
  • 在评估人工智能痴呆症预测模型在多样化,现实世界的临床数据上的表现方面存在差距.

研究的目的:

  • 通过使用现实世界英国国家卫生服务 (NHS) 数据,评估在大型研究数据集上训练的AI模型对痴呆症预测的概括性.
  • 评估人工智能驱动的磁共振成像 (MRI) 分析在预测痴呆症诊断时间方面的有效性.

主要方法:

  • 分析了SLaM NHS信托机构1140名患者的3D T1加权MRI扫描和电子健康记录.
  • 在国家阿尔茨海默氏症协调中心 (NACC) 和阿尔茨海默氏症神经成像倡议 (ADNI) 数据集上训练的AI模型 (3D ResNet) 应用于SLaM队列.
  • 阿尔茨海默病痴呆症 (p_AD) 的概率与临床共变量 (年龄,性别,MMSE) 结合使用考克斯比例危险回归来估计诊断的时间.

主要成果:

  • 人工智能模型在SLaM队列中实现了65.3%-68.6%的分类准确率.
  • 该p_AD指标显著预测了诊断的时间,危险比率从3.58到4.67不等 (p<0.0017).
  • 在p_AD中增加0.1与在8年内患痴呆症的风险增加13.6%-16.7%相关.

结论:

  • 在大型研究数据集上训练的AI模型在预测现实世界NHS患者群体中痴呆症进展方面表现出有效性.
  • 该研究强调了人工智能模型在不同临床环境中用于痴呆风险预测的临床实用性和通用性.
  • 人工智能驱动的神经成像数据的分析显示,改善痴呆症的早期检测和管理具有前途.